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The purpose of  our study is to investigate 
suppression of  puberty for transgender teens. We 
will examine current treatments, developing 
treatments, ethical limitations, and the overarching 
questions that cause hesitation in healthcare 
providers. Many of  the issues faced by these 
children stem from their age, and thus their ability 
to make rational decisions for themselves. Proposals 
against treatment can create psychosocial 
developmental issues in teens and increase 
developing gender dysphoria; the psychological 
distress that results from the inability to align one’s 
assigned sex with their new gender identity. But 
fears of  regretful decision-making leads to the 
question of  what is more ethical, the postponement 
of  treatment due to lack of  self-awareness or the 
alleviation of  suffering with the risk of  reversal. 
For children under the age of  16, most treatments begin with a focus on 
psychological components of  what it means to be transgender, using specifically 
trained individuals, Mental Health Professionals, to diagnose as accurately as possible 
the signs and symptoms the child may be experiencing. Likely exploring many facets 
of  the child’s life; “the etiology of  dysphoria will prove to have complex biological, 
social, and psychological influences.”
• The Diagnostic and Statistical Manual of  Mental Disorders-5 (DSM-5) states that 
the criteria for the diagnosis of  gender dysphoria in adolescents and adults as the 
presence of  a marked incongruence between one’s experienced/expressed 
gender and assigned gender, lasting for at least 6 months, as manifested by at 
least two of  the following: (1) a marked incongruence between one’s 
experienced/expressed gender and primary and/or secondary sex characteristics 
(or in young adolescents, the anticipated secondary sex characteristics); (2) a 
strong desire to be rid of  one’s primary and/or secondary sex characteristics 
because of  a marked incongruence with one’s experienced/expressed gender (or 
in young adolescents, a desire to prevent the development of  the anticipated 
secondary sex characteristics); (3) a strong desire for the primary and/or 
secondary sex characteristics of  the other gender (or a gender different from that 
assigned at birth); (4) a strong desire to be of  the other gender (or a gender 
different from that assigned at birth); (5) a strong desire to be treated as the other 
gender (or a gender different from that assigned at birth); and (6) a strong 
conviction that one has the typical feelings and reactions of  the other gender (or 
a gender different from that assigned at birth). The individual must also 
experience clinically significant distress or impairment in social, occupational, or 
other important areas of  functioning.
Secondly the use of  continuous gonadotropin-releasing hormone (GnRH) is used in 
children typically till the age of  18
• GnRH has the effect of  blocking the release of  follicle stimulating hormone 
(FSH) and luteinizing hormone (LH) from the pituitary gland. These hormones 
start the process known as puberty.
• The current recommendation is to start GnRH treatment during “the Tanner II 
or III phases” of  puberty, so as to halt the puberty before the child feels its 
biological effects. This gives the child time to assess their feelings about their 
gender identity and sets the stage for them to begin hormone therapy if  they 
wish to transition to another gender.
• Historically, such treatment has not been readily used in persons under 18. Now 
there is strong evidence that waiting this long can increase the chance of  children 
with a long history of  gender dysphoria or GID (gender identity disorder) 
developing a psychiatric disorder or having suicidal thoughts.
This section explores the ethical arguments, both for and 
against puberty blockers.
Case Study #2: 10-years-old
Background
• Assigned as female at birth, identifies as male. Questions regarding identity began at 
the age of  5 and claims that “he wants to be a boy”. Concerns from the mother 
regarding the permanence of  some treatments regarding hormones or surgery. 
Upon the onset of  pubertal changes, patient has experienced severe distress
Diagnosis
• Patient is diagnosed with gender dysphoria which means the gender assigned at 
birth is not the same as the gender the patient identifies as which leads to distress.
Treatment
• Transgender teens often have a high rate of  suicide, self  harm, depression, anxiety, 
eating disorders, as well as social conflicts. Care that affirms the gender the patient 
identifies with through the use of puberty blockers and/or gender- affirming 
hormones can reduce the risk of  the previously mentioned illnesses. Puberty 
blockers are used for the patient
Outcome
• Patient used puberty blockers. Family also recognizes the severity of  distress the 
patient must feel which allows them to seek out a mental health provider. Pursuing 
treatment has improved family relations and decreased some stress on the 
patient. Patient feels confident in their decision and engages in therapy and hopes 
to begin testosterone at the age of  14.
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Non-maleficence and Beneficence (TW//suicide mention)
• A 2020 study by the American Academy of  Pediatrics found 
treatments for gender dysphoria including puberty suppressing 
treatments can be associated with decreased rates of  suicidal 
ideation and illicit drug use throughout the lifetime of  a trans 
patient.
• Puberty suppressing hormones allow the decision to commence 
HRT to be prolonged allowing patients to mature and develop 
their own power of  judgement. 
• Allowing adolescents to avoid the gendered maturation brought 
on by puberty offers the highest likelihood of  preferred results 
for gender transition later in life.
Respect for patient autonomy
• Despite the fact that minors cannot give legal consent to 
treatments does not dismiss the fact that they have a right to 
autonomy. 
• Seeking gender affirming treatment is a very intimate and 
personal decision, puberty suppressors allow kids to not 
experience as much gender dysphoria while making those 
decisions.
• “[puberty blockers] certainly facilitates exploration significantly 
more than letting puberty run its course; whereas puberty 
strongly favors cis embodiment by raising the psychological and 
medical toll of  transitioning”
• A study from the American Academy of  Pediatrics found that 
only 2.5% of  patients with gender dysphoria who wanted 
puberty suppressing hormone treatment actually got it. 
For
Informed consent and nonmaleficence
• Early medical transition is irreversible and could lead to sterility later 
in life
• Need for more long-term studies to consider the age and 
cognitive development of  kids with gender dysphoria.
• However, many trans patients report that feeling comfortable 
in their own bodies far outweighs the “harm” of  losing the 
ability to procreate.
• Trans kids are put into a tough position because if  they don’t 
transition, they can face all kinds of  stigma and danger for being 
gender non-conforming and not “passing”, but if  they do use 
medical interventions to transition, they are making an irreversible 
decision. Ultimately, as a society, we need to give children the 
support and the space, they need to question their gender without 
putting pressure on trans people to be “passing”. One way to ensure 
this is through the use of psychological treatments for adolescents in 
order to allow the child time to mature and evaluate their decision to 
ensure that it will be one that affirms their gender identity.
This discussion surrounding the suppression of  puberty in 
transgender teens is important when we consider the 
disproportionate number of  suicide and mental health 
issues in the transgender population. These concerns for 
alleviating body dysphoria are valid to consider as some 
interventions have the potential to avoid those feelings of  
dysphoria before puberty begins. By preventing these 
physical, emotional, and hormonal changes to take place, it 
may lead to an easier transitioning process for these teens. 
However, there are concerns to keep in mind during this 
discussion: age of  consent, irreversible physical/hormonal 
changes, and the potential for a teen’s gender identity to 
change later in life. In this discussion, we will evaluate the 
scientific changes from these interventions, ethical 
concerns, a case study example, and the future implications 
of  this process.
Introduction
Against
Then there is sex hormone treatments, which are practically irreversible and requires 
sufficient mental capacity to make an informed decision. 
• Many scientists and medical professionals are concerned about allowing 
adolescents to make lasting decisions about their health and gender when there 
has been scientific research showing that during adolescence, the great amount of  
neurological development occurring during this time impacts the “processing 
















Case Study #1: 18-years-old
Background
• Assigned as female at birth, at the age of  5, Phoenix identified as gender non-binary. At 
the age of  11 during the time of  puberty, the patient underwent severe distress 
regarding pubescent changes and requested puberty blockers. The doctor and patient 
agreed to reconvene upon Phoenix turning 16 to further assess treatment options. This 
also allowed time for gender identity to solidify. 
Diagnosis
• Phoenix does not have any underlying medical conditions. Patient is diagnosed with 
gender dysphoria. Doctor has started the current course of  treatment and has agreed to 
re-evaluate further measures to be taken after 2 years. 
Treatment
• Phoenix has been treated with puberty blockers and has requested from her physician to 
continue the blockers long term. Patient also has been referred to a psychologist.
Outcome
• Phoenix wants to continue puberty suppressants 'forever’ and has no desire for their 
body to change. Patient’s physician is hesitant about the request for long term puberty 
suppressants due to physical risks regarding bone health and underlying psychological 
risks regarding issues surrounding growing up. Upon psychological evaluations, Phoenix 
has decided that the need to remain in a pre-pubescent state is the only way to reflect 
the patient’s non-binary identity. Psychologists support Phoenix’s decision to maintain 
puberty blockers as the decision was made with consent, free will, and disclosure of  
outcomes and potential side effects. 
